WASHINGTON, D.C. — Multinational drug corporations want all the credit for the COVID-19 vaccines — but taxpayer funding is overwhelmingly responsible for the new vaccines’ creations. Now, drug companies stand to make billions in profit off of the pandemic and cash in on the public’s massive vaccine investment, Patients For Affordable Drugs says in its latest in a series on taxpayer investment in COVID-19 treatments.
“I am both a taxpayer and a blood cancer patient who is at high risk from COVID-19,” said David Mitchell, the founder of Patients For Affordable Drugs. “It gives me hope to have two vaccination options granted emergency use authorization by the FDA, and a third expected soon. But we have to remember these vaccines would not have happened so fast without the investments by taxpayers. And now drug corporations are cashing in. To pharma, I’d just like to say, ‘You’re welcome.’”
Read the full post here.
|